ACTA1 and diabetic kidney disease: Immunofluorescence imaging shows the protein expression (Figure 3(a)) and fluorescence intensity (Figure 3(c)) of α-SMA was considerably increased in the kidneys of untreated DKD mice, and this was attenuated with YSPDF treatment.